Leptin-deficient mice exhibit atherosclerotic lesions and leptin administration reduces atherosclerosis through the reduction of hypercholesterolemia and liver steatosis as well as through the upregulation of the atheroprotective adiponectin [106,108]. The gene discussed is LEP; the disease is Hypercholesterolemia.